GlassScriptPhysician profile
Juliette A Prust
NPI 1538485362
$1,540.05
in general payments reported to CMS, 2019-2025
22 companies · $586 in 2025
The $586 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.98 · 2020: $125 · 2021: $102 · 2022: $63.00 · 2023: $215 · 2024: $408 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,208.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $184.94 | 2023-2024 | Slynd |
| Astellas Pharma US INC | $153.18 | 2024-2025 | Veozah |
| Pfizer INC. | $143.04 | 2020-2025 | |
| Caldera Medical, INC | $134.22 | 2025 | |
| Daiichi Sankyo INC. | $117.36 | 2019-2021 | |
| Millicent US INC | $115.31 | 2023-2025 | Intrarosa, Femring, Femlyv |
| Abbvie INC. | $105.45 | 2023-2025 | |
| Amgen INC. | $99.24 | 2021-2025 | Evenity, Prolia |
| Mayne Pharma Commercial LLC | $87.59 | 2025 | |
| Merck Sharp & Dohme LLC | $72.70 | 2019-2025 | Gardasil 9 |
| Medtronic, INC. | $64.18 | 2024 | V-Loc 180 |
| Hologic Sales and Service, LLC | $44.17 | 2025 | Aptima, Myosure Tissue Removal Device |
| Sage Therapeutics, LLC | $34.90 | 2025 | Zurzuvae |
| Scynexis, INC. | $31.85 | 2022 | |
| Avion Pharmaceuticals | $29.13 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $26.69 | 2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $22.15 | 2025 | |
| Evofem Biosciences, INC. | $17.68 | 2023 | Phexxi |
| Coopersurgical, INC. | $15.99 | 2025 | Paragard T 380a |
| Sumitomo Pharma America, INC. | $14.49 | 2025 | Gemtesa |
| Seqirus USA INC | $14.14 | 2024 | Fluad, Flucelvax |
| Allergan, INC. | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juliette Prust listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.